Retractable Technologies, Inc.
General ticker "RVP" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $22.5M (TTM average)
Retractable Technologies, Inc. does not follow the US Stock Market performance with the rate: -16.9%.
Estimated limits based on current volatility of 1.9%: low 0.68$, high 0.70$
Factors to consider:
- Total employees count: 227 (+50.3%) as of 2024
- Top business risk factors: Trade tariffs, Supply chain disruptions, Intellectual property risks, Market competition, Regulatory and compliance
- Price in estimated range
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.54$, 1.28$]
- 2026-12-31 to 2027-12-31 estimated range: [0.64$, 1.47$]
Financial Metrics affecting the RVP estimates:
- Positive: with PPE of -2.7 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Inventory ratio change, % of -5.72 <= -0.75
- Positive: Investing cash flow per share per price, % of 24.63 > -0.60
- Positive: -9.70 < Industry operating profit margin (median), % of -3.62
- Positive: -0.03 < Industry operating cash flow per share per price (median), % of 1.67
- Positive: 42.57 < Shareholder equity ratio, % of 52.15 <= 64.23
Short-term RVP quotes
Long-term RVP plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $43.60MM | $33.05MM | $38.27MM |
| Operating Expenses | $55.09MM | $54.16MM | $59.44MM |
| Operating Income | $-11.49MM | $-21.11MM | $-21.18MM |
| Non-Operating Income | $2.57MM | $17.59MM | $8.90MM |
| Interest Expense | $0.15MM | $0.12MM | $0.09MM |
| R&D Expense | $0.58MM | $0.67MM | $0.68MM |
| Income(Loss) | $-8.92MM | $-3.52MM | $-12.27MM |
| Taxes | $-1.91MM | $8.37MM | $0.29MM |
| Net Income(Loss)* | $-7.01MM | $-11.89MM | $-12.57MM |
| Stockholders Equity | $99.29MM | $87.17MM | $74.38MM |
| Inventory | $17.58MM | $19.19MM | $17.19MM |
| Assets | $179.67MM | $160.72MM | $142.63MM |
| Operating Cash Flow | $2.77MM | $-11.56MM | $-7.06MM |
| Capital expenditure | $0.85MM | $1.44MM | $0.54MM |
| Investing Cash Flow | $-10.76MM | $3.66MM | $5.98MM |
| Financing Cash Flow | $0.94MM | $-0.54MM | $-0.57MM |
| Earnings Per Share** | $-0.23 | $-0.40 | $-0.42 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.